Photo Source: Moscow Mayor's Office Press Service
According to the list, hospitals are planned to receive key equipment and components for radionuclide diagnostics and high-tech imaging: gamma cameras for planar and specialized studies, including scintigraphy and functional organ studies, single-photon emission computed tomographs (SPECT), combined SPECT/CT and PET/CT systems, as well as workstations and picture archiving and communication systems (PACS).
In addition, the list includes medical devices used in radiation diagnostics and therapy, including equipment for working with contrast agents.
In 2025, Russia launched a special program for the development of nuclear medicine – primarily radionuclide diagnostics. As a result, by 2030, new SPECT rooms will be opened in 26 regions, new PET/CT systems will appear in 19 hospitals, and equipment will be upgraded in 18 existing PET/CT departments.
The number of diagnostic studies using radiopharmaceuticals in the Russian Federation reached 1 million cases per year by 2025. The total number of patients treated with such drugs is 28,000, reported Health Minister Mikhail Murashko in December. It is also planned to create a unified system for the production and delivery of radiopharmaceuticals with the participation of Rosatom.
Currently, more than 60 radiopharmaceuticals are used in Russia. The number of diagnostic radiopharmaceuticals is planned to increase by 16% over five years, and therapeutic ones by 60% compared to current levels.
In 2019–2024, the development of nuclear medicine was also part of the federal project "Fight Against Cancer." Thanks to the purchase of new equipment and production of radiopharmaceuticals, over five years of project implementation, the availability of modern diagnostic equipment in medical institutions has increased significantly: the number of CT scanners increased by 49.3%, SPECT and SPECT/CT systems by 10%, and MRI by 30%. This made it possible to increase the volume of critical diagnostic procedures: for example, the number of PET-CT studies grew from 39,477 in 2018 to 167,287 in 2022, and SPECT studies from 10,039 to 18,960.
For more details on how radionuclide therapy and diagnostics are used in Russia, see the overview by Marus Media.
Source: Ministry of Health of the Russian Federation
All information on this website is provided for informational purposes only and does not constitute medical advice. All medical procedures require prior consultation with a licensed physician. Treatment outcomes may vary depending on individual characteristics. We do not guarantee any specific results. Always consult a medical professional before making any healthcare decisions.